UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 26

Sortiert nach

New concepts in neurology education: successful implementation of flipped classroom lectures

Neurological research and practice, 2022-08, Vol.4 (1), p.31-31, Article 31

2022

Volltextzugriff (PDF)

Comparative study of virus and lymphocyte distribution with clinical data suggests early high dose immunosuppression as potential key factor for the therapy of patients with BoDV-1 infection

Emerging microbes & infections, 2024-12, Vol.13 (1), p.2350168-2350168

2024

Volltextzugriff (PDF)

Aldehyde dehydrogenase 1A1—a new mediator of resistance to temozolomide in glioblastoma

Neuro-oncology (Charlottesville, Va.), 2012-12, Vol.14 (12), p.1452-1464

2012

Volltextzugriff (PDF)

Residents as teachers in Neurology: a Germany-wide survey on the involvement of neurological residents in clinical teaching

Neurological research and practice, 2022-05, Vol.4 (1), p.17-17, Article 17

2022

Volltextzugriff (PDF)

Amino acid PET vs. RANO MRI for prediction of overall survival in patients with recurrent high grade glioma under bevacizumab therapy

European journal of nuclear medicine and molecular imaging, 2024-05, Vol.51 (6), p.1698-1702

2024

Volltextzugriff (PDF)

Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide

Neuro-oncology (Charlottesville, Va.), 2016-11, Vol.18 (11), p.1529-1537

2016

Volltextzugriff (PDF)

The glioblastoma multiforme tumor site promotes the commitment of tumor-infiltrating lymphocytes to the TH17 lineage in humans

Proceedings of the National Academy of Sciences - PNAS, 2022-08, Vol.119 (34), p.1-e2206208119

2022

Volltextzugriff (PDF)

Mobile Apps in Oncology: A Survey on Health Care Professionals' Attitude Toward Telemedicine, mHealth, and Oncological Apps

Journal of medical Internet research, 2016-11, Vol.18 (11), p.e312-e312

2016

Volltextzugriff (PDF)

Resolving spatial response heterogeneity in glioblastoma

European journal of nuclear medicine and molecular imaging, 2024-06

2024

Volltextzugriff (PDF)

Adjuvant re-irradiation vs. no early re-irradiation of resected recurrent glioblastoma: pooled comparative cohort analysis from two tertiary centers

Journal of neuro-oncology, 2024-05, Vol.168 (1), p.49-56

2024

Volltextzugriff (PDF)

The glioblastoma multiforme tumor site promotes the commitment of tumor-infiltrating lymphocytes to the T H 17 lineage in humans

Proceedings of the National Academy of Sciences - PNAS, 2022-08, Vol.119 (34)

2022

Volltextzugriff (PDF)

Validation of an established prognostic score after re-irradiation of recurrent glioma

Acta oncologica, 2017-03, Vol.56 (3), p.422-426

2017

Volltextzugriff (PDF)

A Second Course of Radiotherapy in Patients with Recurrent Malignant Gliomas: Clinical Data on Re-irradiation, Prognostic Factors, and Usefulness of Digital Biomarkers

Current treatment options in oncology, 2019-09, Vol.20 (10), p.71-71, Article 71

2019

Volltextzugriff (PDF)

Aldehyde dehydrogenase 1A1--a new mediator of resistance to temozolomide in glioblastoma

Neuro-oncology (Charlottesville, Va.), 2012-12, Vol.14 (12), p.1452-1464

2012

Volltextzugriff (PDF)

RTHP-26. FEASIBILITY OF A CONCOMITANT ADMINISTRATION OF ALTERNATING ELECTRIC FIELDS AND RADIOTHERAPY – A PLANNING STUDY

Neuro-oncology (Charlottesville, Va.), 2017-11, Vol.19 (suppl_6), p.vi224-vi224

2017

Volltextzugriff (PDF)

Neurological teaching in times of crisis

GMS journal for medical education, 2020-01, Vol.37 (7), p.Doc69-Doc69

2020

Volltextzugriff (PDF)

CTNI-07. LOMUSTINE/TEMOZOLOMIDE CHEMOTHERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED IDHWT GLIOBLASTOMA ACCORDING TO CETEG/NOA-09: REAL-WORLD EXPERIENCE IN A MULTICENTER COHORT

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii71-vii71

2022

Volltextzugriff (PDF)

The algorithms of adjuvant therapy in gliomas and their effect on survival

Journal of neurosurgical sciences, 2019-04, Vol.63 (2), p.179

2019

Volltextzugriff (PDF)

Exploring molecular glioblastoma: Insights from advanced imaging for a nuanced understanding of the molecularly defined malignant biology

Neuro-oncology advances, 2024-01, Vol.6 (1), p.vdae106

2024

Volltextzugriff (PDF)

NCOG-10. FACTORS INFLUENCING NEUROCOGNITIVE FUNCTION IN PATIENTS WITH NEUROEPITHELIAL TUMORS

Neuro-oncology (Charlottesville, Va.), 2017-11, Vol.19 (suppl_6), p.vi139-vi140

2017

Volltextzugriff (PDF)

Toward image-based personalization of glioblastoma therapy: A clinical and biological validation study of a novel, deep learning-driven tumor growth model

Neuro-oncology advances, 2024-01, Vol.6 (1), p.vdad171-vdad171

2024

Volltextzugriff (PDF)

Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.2001-2001

2015

Volltextzugriff (PDF)

Bessere Prognose von Low-grade-Gliomen durch multimodale Therapie?

InFo Onkologie, 2016-11, Vol.19 (7), p.24-26

2016

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect

ThemaBrain Cancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(25)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

New concepts in neurology education: successful implementation of flipped classroom lectures

Comparative study of virus and lymphocyte distribution with clinical data suggests early high dose immunosuppression as potential key factor for the therapy of patients with BoDV-1 infection

Aldehyde dehydrogenase 1A1—a new mediator of resistance to temozolomide in glioblastoma

Residents as teachers in Neurology: a Germany-wide survey on the involvement of neurological residents in clinical teaching

Amino acid PET vs. RANO MRI for prediction of overall survival in patients with recurrent high grade glioma under bevacizumab therapy

Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide

The glioblastoma multiforme tumor site promotes the commitment of tumor-infiltrating lymphocytes to the TH17 lineage in humans

Mobile Apps in Oncology: A Survey on Health Care Professionals' Attitude Toward Telemedicine, mHealth, and Oncological Apps

Resolving spatial response heterogeneity in glioblastoma

Adjuvant re-irradiation vs. no early re-irradiation of resected recurrent glioblastoma: pooled comparative cohort analysis from two tertiary centers

The glioblastoma multiforme tumor site promotes the commitment of tumor-infiltrating lymphocytes to the T H 17 lineage in humans

Validation of an established prognostic score after re-irradiation of recurrent glioma

A Second Course of Radiotherapy in Patients with Recurrent Malignant Gliomas: Clinical Data on Re-irradiation, Prognostic Factors, and Usefulness of Digital Biomarkers

Aldehyde dehydrogenase 1A1--a new mediator of resistance to temozolomide in glioblastoma

RTHP-26. FEASIBILITY OF A CONCOMITANT ADMINISTRATION OF ALTERNATING ELECTRIC FIELDS AND RADIOTHERAPY – A PLANNING STUDY

Neurological teaching in times of crisis

CTNI-07. LOMUSTINE/TEMOZOLOMIDE CHEMOTHERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED IDHWT GLIOBLASTOMA ACCORDING TO CETEG/NOA-09: REAL-WORLD EXPERIENCE IN A MULTICENTER COHORT

The algorithms of adjuvant therapy in gliomas and their effect on survival

Exploring molecular glioblastoma: Insights from advanced imaging for a nuanced understanding of the molecularly defined malignant biology

NCOG-10. FACTORS INFLUENCING NEUROCOGNITIVE FUNCTION IN PATIENTS WITH NEUROEPITHELIAL TUMORS

Toward image-based personalization of glioblastoma therapy: A clinical and biological validation study of a novel, deep learning-driven tumor growth model

Prognostic relevance of miRNA-155 methylation in anaplastic glioma

ACTR-58. PHASE III TRIAL OF CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA PATIENTS: THE CeTeg/NOA-09 trial

Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide

Bessere Prognose von Low-grade-Gliomen durch multimodale Therapie?

Aktive Filter

Suchergebnisse filtern